468
Participants
Start Date
November 30, 2004
Primary Completion Date
March 31, 2005
Study Completion Date
March 31, 2005
Haemophilus influenzae type b- and meningococcal (vaccine)
GSK Investigational Site, Almeira
GSK Investigational Site, Madrid
GSK Investigational Site, Madrid
GSK Investigational Site, Madrid
GSK Investigational Site, Madrid
GSK Investigational Site, Getafe
GSK Investigational Site, Alcorcón
GSK Investigational Site, Móstoles/Madrid
GSK Investigational Site, Málaga
GSK Investigational Site, Valladolid
GSK Investigational Site, Basurto/Bilbao
GSK Investigational Site, Barcelona
GSK Investigational Site, Barcelona
GSK Investigational Site, Burgos
GSK Investigational Site, Palma de Mallorca
GSK Investigational Site, Vélez-Málaga
Lead Sponsor
GlaxoSmithKline
INDUSTRY